PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 141 filers reported holding PUMA BIOTECHNOLOGY INC in Q2 2019. The put-call ratio across all filers is 0.78 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $9,113,000 | -23.6% | 1,300,000 | 0.0% | 2.12% | -15.2% |
| Q2 2021 | $11,934,000 | -5.6% | 1,300,000 | 0.0% | 2.50% | -4.2% |
| Q1 2021 | $12,636,000 | -5.3% | 1,300,000 | 0.0% | 2.61% | +20.6% |
| Q4 2020 | $13,338,000 | +19.9% | 1,300,000 | +18.0% | 2.17% | +116.6% |
| Q3 2020 | $11,120,000 | +1052.3% | 1,102,073 | +1091.4% | 1.00% | +1198.7% |
| Q2 2020 | $965,000 | -97.2% | 92,502 | -89.7% | 0.08% | -97.8% |
| Q1 2019 | $34,911,000 | +24.3% | 900,000 | -34.8% | 3.46% | -2.6% |
| Q4 2018 | $28,077,000 | -99.9% | 1,379,700 | +175.9% | 3.55% | -29.8% |
| Q1 2018 | $34,025,000,000 | – | 500,000 | – | 5.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 1,417,000 | $18,010,000 | 2.24% |
| Palo Alto Investors LP | 1,405,680 | $17,866,000 | 0.87% |
| PFM Health Sciences, LP | 2,838,376 | $36,076,000 | 0.68% |
| TANG CAPITAL MANAGEMENT LLC | 349,400 | $4,441,000 | 0.60% |
| Capital Impact Advisors, LLC | 127,029 | $1,615,000 | 0.59% |
| Leap Investments LP | 29,100 | $370,000 | 0.50% |
| Spark Investment Management LLC | 454,300 | $5,774,000 | 0.40% |
| Partner Investment Management, L.P. | 27,567 | $350,000 | 0.37% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 262,945 | $3,342,000 | 0.26% |
| Rock Springs Capital Management LP | 534,400 | $6,792,000 | 0.25% |